Le Lézard
Classified in: Health, Business
Subjects: PSF, SCZ, DEI

Marketing Can Mislead Older Adults During Medicare Open Enrollment


Senior Medicare Patrol Resource Center

WASHINGTON, Oct. 25, 2023 /PRNewswire/ -- During Medicare's Open Enrollment Period (OEP), which takes place October 15 through December 7 each year, Medicare beneficiaries can choose Medicare plans that are best for them. Beneficiaries enrolled in Original Medicare can compare and change prescription drug plans (Part D) and Medigap plans.

The Senior Medicare Patrol (SMP) wants everyone on Medicare to know that during OEP, plans and third-party marketing organizations are marketing their products through television ads, social media ads, radio ads, and mailings. "To get your attention, ads may mislead you into thinking one plan is better for you than another. It's important to understand what agents aren't allowed to do so you'll be prepared if someone tries to contact you this OEP." ? Nicole Liebau, Senior Medicare Patrol Resource Center Director.

If you meet with an agent, know that they cannot do the following. If this happens to you, report it to the SMP or SHIP.

Agents cannot:

Comparing plans and knowing what is best for you can be overwhelming. You can get free, unbiased help comparing Medicare plans from the State Health Insurance Assistance Programs (SHIPs). You can locate your local SHIP by visiting www.shiphelp.org or by calling toll-free 877-839-2675.

The SMPs empower and assist Medicare beneficiaries, their families, and caregivers to prevent, detect, and report health care fraud, errors, and abuse. They are located in all 50 states plus Puerto Rico, Guam, The U.S. Virgin Islands, and the District of Columbia. To report Medicare fraud, errors, or abuse, visit www.smpresource.org or call 1-877-808-2468.

Contact: Nicole Liebau
Email: [email protected]

SOURCE SMP Resource Center


These press releases may also interest you

at 06:45
Future Market Insights (FMI) predicts a robust future for the scaffold technology market. This growth is primarily driven by advancements in tissue engineering and regenerative medicine. As these fields develop, demand for innovative scaffold...

at 06:45
Revenue in Q1 2024 increased 26%, driven by Mounjaro, Zepbound, Verzenio and Jardiance. Pipeline progress included positive results from two Phase 3 trials of tirzepatide for obstructive sleep apnea; submission of mirikizumab for Crohn's disease in...

at 06:40
Associated Medical Professionals of NY (A.M.P.) is pleased to announce that internationally recognized radiation oncology physician, researcher and thought leader Steven E. Finkelstein, M.D., DABR, FACRO, has joined its care team as Director of the...

at 06:30
  All proposals of Board of Directors approvedGilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for election confirmedMathai Mammen, Graeme Pitkethly and Michael Rechsteiner elected as new Board...

at 06:30
Company delivers strong first quarter results:Sales of $8.0 billion, down 0.3% YoY; adjusted sales of $7.7 billion with organic growth up ~1% YoYGAAP earnings per share of $1.67, down 5% YoY; adjusted earnings of $2.39, up double digits...

at 06:30
...



News published on and distributed by: